| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |